Table IV.
Univariate and multivariate analysis of clinical variables associated with relapse-free survival in patients with lung cancer.
| Univariate | Multivariate univariate | |||
|---|---|---|---|---|
| Characteristics | Category | P-value | HR (95% CI) | P-value |
| Age | ≤69 vs. >69 | 0.213 | ||
| Gender | Male vs. Female | 0.458 | ||
| Maximum tumor size | ≤26 vs. >26 | <0.001 | ||
| Lymph node metastasis | Negative vs. Positive | <0.001 | ||
| Pleural invasion | Negative vs. Positive | 0.002 | ||
| Venous invasion | Negative vs. Positive | <0.001 | 4.596 (2.053–10.053) | <0.001 |
| Pathological stage | Stage I vs. Stage II/III | <0.001 | 3.347 (1.685–6.685) | 0.001 |
| Differentiation | Well vs. Moderate/Poor | <0.001 | ||
| CD117 expression | Negative vs. Positive | 0.014 | 3.352 (1.583–7.583) | 0.002 |
HR, hazard ratio; CI, confidence interval; CD, cluster of differentiation.